CAPTRUST Financial Advisors’s Immunome IMNM Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Buy	+60,046	New	+$1.28M	﹤0.01%	1606

Other funds holding IMNM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

CAPTRUST Financial Advisors's IMNM Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Immunome (IMNM) in Q2 2026: 60,046 shares worth $1.27M. The stake represents ﹤0.01% of the portfolio and ranks #1606 among its holdings.

202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

CAPTRUST Financial Advisors held 60,046 shares of Immunome worth $1.27M as of Q2 2026.
Immunome was a new CAPTRUST Financial Advisors position in Q2 2026.
Immunome made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1606 holding.
202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.